News and Events

Marlins Triple Play 5K


Please join us for the 3rd Annual Marlins Triple Play 5K, presented by UHealth, on November 3rd, 2024! People of …

2024 CReATe Consortium Annual Meeting


Sunday, August 18th, 2024 through Tuesday, August 20th, 2024, Dr. Michael Benatar at the University of Miami will be hosting …

Advancing Hope: AFTD Attends C9orf72 FTD/ALS Prevention Trial Workshop


Dr. Adam Boxer at the University of California San Francisco and Dr. Michael Benatar at the University of Miami hosted …

Walk to Defeat ALS – ALS Association


Help us unlock ALS on the Walk to Defeat ALS Miami hosted by the ALS Association! Saturday, May 18, 2024 …

Strike Out ALS Night


Please join us at Alex Rodriguez Park at Mark Light Field on March 29th, 2024, as our Miami Hurricanes take …

The Genetics Podcast EP 121: Breakthroughs and insights in ALS research with Dr. Michael Benatar


Listen Now

JNNP Podcast: A roadmap to ALS prevention: strategies and priorities


Listen Now

Inside U Miami Medicine Podcast: Unraveling the Mysteries of ALS


Listen Now

2024 Annual ALS Patient Symposium


The ALS Patient Symposium is an annual event, offering patients, family members and health care providers an opportunity to learn …

Dr. Michael Benatar Honored for Innovative ALS Discoveries


University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., was one of seven researchers who received the Sean …

2023 Impact Report: ALS Center at the University of Miami


The University of Miami’s ALS Center has released the 2023 Impact Report, highlighting the pioneering research and comprehensive care conducted …

Marlins Triple Play 5K


Please join us for the 2nd Annual Marlins Triple Play 5K, presented by UHealth, on December 16, 2023! People of …

Guiding Clinical Care for People at Risk for ALS and FTD


An international workshop co-led by University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., laid the foundation for developing …

International Workshop Focuses on Defining Prodromal Phases of ALS, FTD


Michael Benatar, M.D., Ph.D., at the University of Miami organized and hosted the Second International Pre-Symptomatic ALS Workshop on February …

New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS


Read the full update at the link below. View update

CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS


Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a Professor of Neurology at the University of Miami …

Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases


October 22, 2021 (University Of Miami press release) A groundbreaking clinical trial for unaffected individuals at risk for a genetic …

Learn how you can contribute to ALS research by donating CSF


Many neurological disorders are poorly understood, in large part because researchers have few opportunities to directly study the brain and …

Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation


December 9, 2020 (University Of Miami press release) For more than a decade, investigators at the University of Miami Miller …

ALS Center investigators host first international Pre-Symptomatic ALS Workshop


The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on …

Rare Diseases are Not Rare but Awareness is Endangered


To help raise awareness about rare diseases, the National Center for Advancing Translation Science (NCATS) hosts an annual ‘Rare Diseases …

The Future Is Now: ALS Research at the University of Miami


The ALS Center’s own Michael Benatar MD, PhD spoke on “The Future is Now: ALS Research at the University of …

Biomarkers for ALS Therapy Development


  Dr. Michael Benatar, Executive Director of the University of Miami’s ALS Center, gave a webinar about Biomarkers at the …

University of Miami ALS Center to Receive Critical Funding from the State of Florida


September 25, 2020 (University Of Miami press release) On June 29, 2020, Governor Ron DeSantis approved $800,000 in funding for …

Research survey for rare disease patients and their families about impacts of COVID-19


How is the novel coronavirus pandemic impacting people with rare diseases and their families? Complete the 20-minute research survey from …

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies


May 8, 2020 (University Of Miami press release) “Therapy development for ALS is challenging for many reasons,” said Michael Benatar, …

CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant


October 4, 2019 (University of Miami press release) An international research consortium led by investigators at the University of Miami …

The Kess Golf Cup in New York


The Kess Golf Cup is an annual golf day organized by Paul, Mark and Barbara Kessenich, children of the late …

Annual Memorial Service at Oleta River State Park


Our Annual Memorial Service offers a non-denominational opportunity to remember and celebrates the lives of those who have lost the …

Annual ALS Patient Symposium


The ALS Patient Symposium is an annual educational event, offering patients, family members and health care providers an opportunity to …

University of Miami ALS Center Annual ALS Gala


With amazing silent auctions, delectable cuisine, VIP cocktails and music, our annual ALS Gala offers a night of excitement, fun …

ALS Recovery Fund 17th Annual 5K/10K Walk/Run in Coconut Grove


Every year the ALS Recovery Fund (www.alsrecovery.org) hosts a 5K/10K Walk/Run to raise funds that support ALS patient care and …

UM and Orphazyme Announce Successful Phase II Trial of Arimoclomol in ALS Patients


Data presented at international symposium demonstrate safety and preliminary evidence of efficacy Arimoclomol, a heat shock protein-based therapy, shows promise …

Biomarker for ALS disease progression identified


February 27, 2017 (University of Miami press release) The absence of suitable biomarkers for amyotrophic lateral sclerosis (ALS) poses a …

Join our family - together, we can change the course of this disease.

Join our family

Together, we can change the course of this disease.